ROLE OF SERUM IRON AND ITS ASSOCIATION WITH ANEMIC PREVALANCE AMONG PATIENTS WITH DIFFERENT TYPE OF CANCER
DOI:
https://doi.org/10.29121/granthaalayah.v5.i5(SE).2017.1965Keywords:
Anemia, Iron, Trace Element & CancerAbstract [English]
Cancer is a group of diseases in which cells are aggressive, invasive and sometimes metastatic. Nutritional status an important factor that contributes to immune competence for which trace minerals plays a crucial role in the biochemical and physiological activity of the system. Trace element a category of minerals essential for the biological system and plays an active role in immune effector mechanism. Normal range of iron essential for body metabolism, iron deficiencies leads to anemia which might complicate the event of tumor genesis.
Study involved 50 volunteers (36 females, 14 males) of cancer patients of Mohan Nursing Home Madurai. Serum was collected in the informed consent of the patients. Serum iron level was quantified using Atomic Absorption Spectrophotometer.
Study documented percentage deviation of serum iron concentration (85%) with severe anemic prevalence from the control individual (without cancer) and also establish an association of iron deficiency with anemic prevalence.
Study documented the existence of Iron deficiency which is the most common cause of anemia worldwide. Iron plays a role in oxygen transfer in cytochromes, protein molecules involved in the production of energy in cells and also exhibit certain properties to facilitate antitumor status. Study concludes that serum iron modulations need to be emphasized to minimize the burdenization of the host with Clinical associated complications of Iron deficiency among patients with cancer.
Downloads
References
P. A. Dervan Jefferson, NC: McFarland , (1999).Understanding Cancer.
Stevens RG, Jones DY, Micozzi MS, Taylor PR(1988). Body iron stores and the risk of cancer. N Engl J Med; 319: 1047-52 DOI: https://doi.org/10.1056/NEJM198810203191603
Stevens RG, Graubard BI, Micozzi MS, Neriishi K, Blumberg SB(1994). Moderate elevation of body iron level and increased risk of cancer occurrence and death. Int J Cancer; 56: 364-9 DOI: https://doi.org/10.1002/ijc.2910560312
Lipschitz DA, Cook JD, Finch CA(1974). A clinical evaluation of serum ferritin as an index of iron stores. New Engl J Med; 290: 1213–6 DOI: https://doi.org/10.1056/NEJM197405302902201
Xi Huang(2008). Does iron have a role in breast cancer? Lancet Oncol.; 9(8): 803–807.
Halliwell B: Free radicals, antioxidants, and human disease: curiosity,cause, or consequence? Lancet 344, 721–724, 1994. DOI: https://doi.org/10.1016/S0140-6736(94)92211-X
Aslan M, Horoz M, Kocyigit A, Ozgonul S, Celik H, et al(2006).Lymphocyte DNA damage and oxidative stress in patients with iron deficiency anemia. Mutat Res 601, 144–149, 8. DOI: https://doi.org/10.1016/j.mrfmmm.2006.06.013
Aust AE and Eveleigh JF: Mechanisms of DNA oxidation (1999). Proc Soc ExpBiol Med 222, 246–252 DOI: https://doi.org/10.1046/j.1525-1373.1999.d01-141.x
Vives Corrons JL, Miguel-Garcia A, Pujades MA, Miguel-Sosa A, Cambiazzo S, et al(1995). Increased susceptibility of microcytic red blood cells to in vitro oxidative stress. Eur J Haematol 55, 327–331. DOI: https://doi.org/10.1111/j.1600-0609.1995.tb00705.x
Kumerova A, Lece A, Skesters A, Silova A, and Petuhovs V(1998). Anaemia and antioxidant defence of the red blood cells. Mater Med Pol 30, 12–15.
Huang Z, Komninou D, Kleinman W, Pinto JT, Gilhooly EM, et al(2007). Enhanced levels of glutathione and protein glutathiolation in rat tongue epithelium during 4-NQO-induced carcinogenesis. Int J Cancer 120, 1396–1401. DOI: https://doi.org/10.1002/ijc.22525
John P. Richie, Wayne Kleinman, Patricia Marina, Patricia Abraham, and Ernst L.Wynder, Joshua E. Muscat (2008). Blood Iron, Glutathione, and Micronutrient Levels and the Risk of Oral Cancer. Nutrition and Cancer, 60(4), 474–482. DOI: https://doi.org/10.1080/01635580801956477
GD Demetri (2001), Anaemia and its functional consequences in cancer patients: current challenges in management and prospects for improving therapy, British Journal of Cancer 84 (Supplement 1), 31–37. DOI: https://doi.org/10.1054/bjoc.2001.1750
Downloads
Published
How to Cite
Issue
Section
License
With the licence CC-BY, authors retain the copyright, allowing anyone to download, reuse, re-print, modify, distribute, and/or copy their contribution. The work must be properly attributed to its author.
It is not necessary to ask for further permission from the author or journal board.
This journal provides immediate open access to its content on the principle that making research freely available to the public supports a greater global exchange of knowledge.
